(NASDAQ: IRTC) Irhythm Technologies's forecast annual revenue growth rate of 16.16% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.37%, and it is also forecast to beat the US market's average forecast revenue growth rate of 8.88%.
Irhythm Technologies's revenue in 2024 is $513,174,000.On average, 5 Wall Street analysts forecast IRTC's revenue for 2024 to be $18,171,597,068, with the lowest IRTC revenue forecast at $18,121,082,738, and the highest IRTC revenue forecast at $18,233,682,415. On average, 5 Wall Street analysts forecast IRTC's revenue for 2025 to be $21,452,975,595, with the lowest IRTC revenue forecast at $21,255,521,798, and the highest IRTC revenue forecast at $21,564,704,335.
In 2026, IRTC is forecast to generate $25,047,829,133 in revenue, with the lowest revenue forecast at $24,494,473,265 and the highest revenue forecast at $25,601,185,002.